Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myotonic Dystrophy Type-2”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableLooking for participantsNCT04003363
What this trial is testing

The United Kingdom National Registry for Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy
Newcastle University 900
Large-scale testing (Phase 3)Enrolling By InvitationNCT06549400
What this trial is testing

An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 Who Have Completed MEX-DM-302 Study.

Who this might be right for
Myotonic Dystrophy
Lupin Ltd. 176
Not applicableUnknownNCT02708784
What this trial is testing

An MRI Study on Muscular Diseases -Pompe Disease and Dystrophia Myotonica-

Who this might be right for
Glycogen Storage Disease Type 2Dystrophia Myotonica
University of Aarhus 60
Not applicableUnknownNCT03211923
What this trial is testing

Muscle Relaxation in Myopathies With Positive Muscle Phenomena

Who this might be right for
Nemaline Myopathy Type 6Myotonic Dystrophy Type 2McArdle Disease
Radboud University Medical Center 30
Large-scale testing (Phase 3)WithdrawnNCT04700046
What this trial is testing

Study to Investigate the Efficacy and Safety of Mexiletine in Patients With Myotonic Dystrophy Type 1 and Type 2

Who this might be right for
Myotonic Dystrophy Type 1 and Type 2
Lupin Ltd.
Not applicableEnded earlyNCT03867435
What this trial is testing

Assessing Clinical Endpoints and Biomarkers in Myotonic Dystrophy Type-1 and Type 2 (ASCEND-DM)

Who this might be right for
Myotonic Dystrophy Type-1Myotonic Dystrophy Type-2
National Institute of Neurological Disorders and Stroke (NINDS) 4
Large-scale testing (Phase 3)Looking for participantsNCT06523400
What this trial is testing

The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2

Who this might be right for
Myotonic Dystrophy
Lupin Ltd. 176
Not applicableLooking for participantsNCT06716931
What this trial is testing

Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)

Who this might be right for
Myotonic Dystrophy 2
Massachusetts General Hospital 24
Not applicableStudy completedNCT04907162
What this trial is testing

Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders

Who this might be right for
Pompe Disease (Late-onset)Myotonic Dystrophy Type 1 (DM1)Myotonic Dystrophy Type 2+4 more
LMU Klinikum 82
Not applicableStudy completedNCT03087526
What this trial is testing

NIPD on CFTC for Triplet Repeat Diseases

Who this might be right for
Non Invasive Prenatal Diagnosis
University Hospital, Montpellier 60
Not applicableEnrolling By InvitationNCT05854433
What this trial is testing

Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2

Who this might be right for
Myotonic Dystrophy Type 2Myotonic Dystrophy Type 1
Wake Forest University Health Sciences 100
Not applicableLooking for participantsNCT00082108
What this trial is testing

Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry

Who this might be right for
Myotonic DystrophyFacioscapulohumeral Muscular DystrophyMuscular Dystrophy+6 more
University of Rochester 3,000
Not applicableStudy completedNCT03603171
What this trial is testing

Clinical Outcome Measures in Myotonic Dystrophy Type 2

Who this might be right for
Myotonic Dystrophy Type 2
Prof. Dr. Benedikt Schoser 60